Key result
Higher biological age is linked to greater arterial stiffness independent of chronological age.
Why the study?
The interplay among biological age, chronological age, and arterial stiffness remains inconclusive, and whether these associations represent a pathway for higher cardiovascular risk in Black women is unclear.
Does higher biological age increase arterial stiffness in young and early midlife Black and White women?
Cross-Sectional (n=222)
No
Does higher biological age increase arterial stiffness in young and early midlife Black and White women?
Effect estimate: β 0.02 (95% CI 0.00-0.03)
p-value: p=0.03
Biological age is a significant predictor of arterial stiffness independent of chronological age in young to midlife women, highlighting its potential utility in early cardiovascular risk assessment.
May aid early arterial stiffness assessment in midlife women; hypothesis-generating pending longitudinal validation.
Background: Arterial stiffness is a precursor of hypertension and hallmark of vascular aging. Chronological age (CA), a robust determinant of arterial stiffness, is considered an insufficient indicator of aging and disparities associated with disease risk. Biological age (BA), the true age based on physiological decline, is recognized as a better indicator of disease risk however the interplay among BA, CA, and arterial stiffness remains inconclusive. We investigated the associations between BA, CA, and arterial stiffness as a potential pathway for higher cardiovascular risk among Black women and whether race modified these associations. Methods: In 230 women (n=150 White, n=80 Black) enrolled in the Predictive Health Institute cohorts (age range 25-49), arterial stiffness was assessed using carotid-femoral pulse wave velocity (cfPWV), measured by applanation tonometry (SphygmoCor®). BA was estimated using the Klemera-Doubal method from 11 different clinical biomarkers and CA. Accelerated age (AccA) was calculated as the difference between BA and CA. Overall and race-specific associations between BA and arterial stiffness adjusting for sociodemographics, health behaviors, and clinical factors were estimated using multiple linear regression. Results: Overall mean (SD) for CA and BA was 40 (6.1), and 38 (12.1) years, respectively. Mean (SD) for BA, AccA, and cfPWV were 43 (13.1), 1.6 (12.9), and 7.3 (1.1) in Black women and 36 (10.8), -3.2 (10.6), and 6.3 (0.8) in White women (Black-White difference in BA: 6.4 years, P=<0.001). Overall, BA (β=0.02 m/s per year, 95%CI: 0.00, 0.03) predicted cfPWV even after adjustment for CA, without a significant interaction by race (P=0.65). Conclusions: BA is a predictor of arterial stiffness after accounting for CA and additional relevant factors. Although there were no racial differences in this association, both BA and arterial stiffness were higher among Black compared to White women. Longitudinal studies are needed to identify BA patterns and CVD risk in Black women.
No takes yet. Share an insight, caveat, or question.
Spikes et al. (2024) conducted a cross-sectional in Healthy women (free of cardiovascular disease) (n=222). Biological Age (BA) was evaluated on Carotid-femoral pulse wave velocity (cfPWV) (β 0.02, 95% CI 0.00-0.03, p=0.03). Biological age significantly predicted arterial stiffness (β 0.02 m/s per year) after adjusting for chronological age and clinical factors, with no significant interaction by race.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: